إعلان
إعلان

CRMD

CRMD logo

CorMedix Inc.

7.63
USD
برعاية
+0.12
+1.57%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

7.63

0.00
-0.04%

تقارير أرباح CRMD

النسبة الإيجابية المفاجئة

CRMD تفوق 25 من 40 آخر التقديرات.

63%

التقرير التالي

بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$130.07M
/
$0.85
التغير الضمني من Q3 25 (Revenue/ EPS)
+24.74%
/
-32.54%
التغير الضمني من Q4 24 (Revenue/ EPS)
+316.78%
/
+286.36%

CorMedix Inc. earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, CRMD reported earnings of 1.26 USD per share (EPS) for Q3 25, beating the estimate of 0.65 USD, resulting in a 91.46% surprise. Revenue reached 104.28 مليون, compared to an expected 87.74 مليون, with a 18.84% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of 0.85 USD, with revenue projected to reach 130.07 مليون USD, implying an نقصان of -32.54% EPS, and زيادة of 24.74% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, CorMedix Inc. reported EPS of $1.26, beating estimates by 91.46%, and revenue of $104.28M, 18.84% above expectations.
The stock price moved up 2.06%, changed from $11.19 before the earnings release to $11.42 the day after.
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
Based on 9 المحللين, CorMedix Inc. is expected to report EPS of $0.85 and revenue of $130.07M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان